Literature DB >> 34024451

Post-infection Irritable Bowel Syndrome.

Antonio Berumen1, Adam L Edwinson1, Madhusudan Grover2.   

Abstract

Epidemiologic data support that acute gastrointestinal infection is one of the strongest risk factors for development of irritable bowel syndrome (IBS). Risk of post-infection IBS (PI-IBS) seems to be greater with bacterial and protozoal than viral enterocolitis. Younger individuals, women, and those with severe enterocolitis are more likely to develop PI-IBS. Disease mechanisms in animal models and humans involve chronic perturbation of intestinal microbiome, epithelial and neuronal remodeling, and immune activation. These mechanisms can lead to luminal (increased proteolytic activity, altered bile acid composition) and physiologic (increased permeability, transit changes, and visceral hypersensitivity) alterations that can mediate PI-IBS symptoms.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteria; Barrier function; Diarrhea; Gut-brain axis; Infectious gastroenteritis; Inflammation; Microbiome

Mesh:

Year:  2021        PMID: 34024451      PMCID: PMC8144546          DOI: 10.1016/j.gtc.2021.02.007

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.867


  98 in total

Review 1.  Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.

Authors:  Fabiane Klem; Akhilesh Wadhwa; Larry J Prokop; Wendy J Sundt; Gianrico Farrugia; Michael Camilleri; Siddharth Singh; Madhusudan Grover
Journal:  Gastroenterology       Date:  2017-01-06       Impact factor: 22.682

2.  Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

Authors:  Fermín Mearin; Marc Pérez-Oliveras; Antonia Perelló; Jaume Vinyet; Anabel Ibañez; Jordi Coderch; Mónica Perona
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Postinfectious gastrointestinal disorders following norovirus outbreaks.

Authors:  Chad K Porter; Dennis J Faix; Danny Shiau; Jennifer Espiritu; Benjamin J Espinosa; Mark S Riddle
Journal:  Clin Infect Dis       Date:  2012-06-19       Impact factor: 9.079

Review 4.  Abnormal breath testing in IBS: a meta-analysis.

Authors:  Eric D Shah; Robert J Basseri; Kelly Chong; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

Review 5.  Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.

Authors:  Uday C Ghoshal; Kok-Ann Gwee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

6.  Post-infectious irritable bowel syndrome in patients with Shigella infection.

Authors:  Sangwon Ji; Hyojin Park; Dokyong Lee; Young Koo Song; Jae Phil Choi; Sang-In Lee
Journal:  J Gastroenterol Hepatol       Date:  2005-03       Impact factor: 4.029

Review 7.  Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  Alexander C Ford; Brennan M R Spiegel; Nicholas J Talley; Paul Moayyedi
Journal:  Clin Gastroenterol Hepatol       Date:  2009-08-12       Impact factor: 11.382

8.  Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.

Authors:  Caroline Swan; Nathalie P Duroudier; Eugene Campbell; Abed Zaitoun; Margaret Hastings; George E Dukes; Joanne Cox; Fiona M Kelly; Jonathan Wilde; Mark G Lennon; Keith R Neal; Peter J Whorwell; Ian P Hall; Robin C Spiller
Journal:  Gut       Date:  2012-06-08       Impact factor: 23.059

9.  Adrenergic Signaling in Muscularis Macrophages Limits Infection-Induced Neuronal Loss.

Authors:  Fanny Matheis; Paul A Muller; Christina L Graves; Ilana Gabanyi; Zachary J Kerner; Diego Costa-Borges; Tomasz Ahrends; Philip Rosenstiel; Daniel Mucida
Journal:  Cell       Date:  2020-01-09       Impact factor: 41.582

10.  Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study.

Authors:  Kurt Hanevik; Knut-Arne Wensaas; Guri Rortveit; Geir Egil Eide; Kristine Mørch; Nina Langeland
Journal:  Clin Infect Dis       Date:  2014-08-12       Impact factor: 9.079

View more
  1 in total

Review 1.  Clinical Trials of Probiotics in Patients With Irritable Bowel Syndrome: Some Points to Consider.

Authors:  Eamonn M M Quigley
Journal:  J Neurogastroenterol Motil       Date:  2022-04-30       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.